DNA Script Email Format
Biotechnology ResearchÎle-de-france, France51-200 Employees
DNA Script is a biotechnology research company based in Île-de-france, France, focused on enzymatic DNA synthesis. Its core R&D activities include enzyme engineering, surface and nucleotide chemistries, and instrumentation development. The company markets the SYNTAX platform, a benchtop DNA printer powered by enzymatic technology, enabling on-demand DNA synthesis for genomics research. The organization is located at 67 Avenue de Fontainebleau le Kremlin-bicêtre, Île-de-france 94270 France, and employs between 51 and 200 people. In 2026, DNA Script signed distribution agreements with Gencell, Bio-Medical Science Co. (BMS), and BioStream Co. to expand global access to SYNTAX. Earlier collaborations include partnerships with Quantoom Biosciences and EVA Pharma, and the company appointed Marc Montserrat as Chief Executive Officer in October 2024.